News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results



8/13/2013 6:21:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, Aug. 13, 2013 — /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences. Read more here: http://www.heraldonline.com/2013/08/13/5109449/intercept-pharmaceuticals-reports.html#storylink=cpy

Hey, check out all the research scientist jobs. Post your resume today!

Read at The Herald


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES